Table 2.

Absorbed doses to the liver, spleen and red marrow, and effective whole-body dose for ⁸⁹Zr-rituximab

	Without preload						With preload
	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Mean ± SD	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Mean ± SD
Liver (mGy/MBq)	1.13	1.08	0.86	0.89	1.21	1.03 ± 0.15	1.22	0.95	0.97	0.95	0.94	1.01 ± 0.12
Red marrow (mGy/MBq)	0.59	0.79	0.59	0.50	0.62	0.62 ± 0.11	0.54	0.58	0.53	0.48	0.54	0.53 ± 0.03
Spleen (mGy/MBq)	12.30	5.35	0.98	0.89	0.92	4.09 ± 4.97	1.10	0.65	0.93	0.53	0.53	0.75 ± 0.26
Whole body (mSv/MBq)	0.68	0.57	0.41	0.40	0.43	0.50 ± 0.12	0.44	0.42	0.42	0.39	0.40	0.41 ± 0.02